Cargando…

Bortezomib Treatment for Refractory PLA2R-Positive Membranous Nephropathy

INTRODUCTION: B-cell depletion has been shown to be an effective strategy for the majority of patients with membranous nephropathy (MN), and in PLA2R-positive MN, immunologic remission (improvement or elimination of measurable serum anti-PLA2R antibodies) precedes renal remission. Yet, cases exist o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geara, Abdallah S., Bhoj, Vijay, Hogan, Jonathan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677711/ https://www.ncbi.nlm.nih.gov/pubmed/36751489 http://dx.doi.org/10.1159/000515087

Ejemplares similares

Horseshoe kidney with PLA2R-positive membranous nephropathy
por: Shi, Shuai-Shuai, et al.
Publicado: (2021)

Successful treatment of PLA(2)R1-antibody positive membranous nephropathy with ocrelizumab
por: Schmidt, Tilman, et al.
Publicado: (2020)

A rare case of PLA2R- and THSD7A-positive idiopathic membranous nephropathy
por: Wanderley, David Campos, et al.
Publicado: (2019)

Rare Occurrence of PLA2R-Positive Membranous Nephropathy in a Patient with Sjogren's Syndrome and CIDP
por: Gupta, Nimish, et al.
Publicado: (2020)

Membranous nephropathy PLA2R+ associated with Chagas disease
por: Xavier-Júnior, José Cândido Caldeira, et al.
Publicado: (2015)

Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection
por: Baker, Lyle W., et al.
Publicado: (2021)

The Role of PLA2R Antibody in Treatment of Membranous Nephropathy
por: Dahan, Karine, et al.
Publicado: (2017)

Favorable outcome in PLA2R positive HBV-associated membranous nephropathy
por: Chen, Ruiying, et al.
Publicado: (2022)

The application of podocyte antigen PLA2R and anti-PLA2R antibody in the diagnosis and treatment of membranous nephropathy
por: Chen, Yang, et al.
Publicado: (2023)

PLA2R antibodies and PLA2R glomerular deposits in psoriasis patients with membranous nephropathy
por: Ge, Yong-Chun, et al.
Publicado: (2016)

First case report of PLA2R-related monotypic (IgG-κ positive) membranous nephropathy concurrent with leukocyte chemotactic factor 2 amyloidosis
por: Xu, Jing, et al.
Publicado: (2023)

PLA2R-Negative Membranous Nephropathy Presenting as a Prodrome of IgG4-Related Autoimmune Pancreatitis
por: Velegraki, Magdalini, et al.
Publicado: (2019)

The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy
por: Cheng, Yan-jiao, et al.
Publicado: (2023)

Anti-PLA(2)R Antibodies in Chinese Patients with Membranous Nephropathy
por: Li, Xin, et al.
Publicado: (2016)

Efficacy and Safety of Rituximab in Hepatitis B Virus–Associated PLA2R-Positive Membranous Nephropathy
por: Berchtold, Lena, et al.
Publicado: (2017)

Risk factors of venous thromboembolism in anti-PLA2R-positive and negative primary membranous nephropathy
por: Wu, Henry H L, et al.
Publicado: (2022)

A Case of Pla2r and Exostosin 1 Positive Membranous Nephropathy - The Diagnostic and Therapeutic Dilemma
por: Sivagnanam, Harish, et al.
Publicado: (2023)

Concurrent PLA2R-Associated Membranous Nephropathy and Antiglomerular Basement Membrane Disease
por: Jagannathan, Geetha, et al.
Publicado: (2022)

Correction: The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy
por: Cheng, Yan-jiao, et al.
Publicado: (2023)

Successful Use of Bortezomib in an Adolescent with Refractory TTP
por: Wali, Junaid Ahmad, et al.
Publicado: (2023)

Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy
por: Guo, Yaling, et al.
Publicado: (2020)

Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy
por: Logt, Anne-Els van de, et al.
Publicado: (2021)

Membranous or membranous‐like GN: A case report of massive proteinuria, positive serum with negative PLA2R on biopsy
por: Kaur, Gurwant, et al.
Publicado: (2018)

Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy
por: Hihara, Kei, et al.
Publicado: (2016)

Bortezomib treatment for refractory nontuberculous mycobacterial infection in the setting of interferon gamma autoantibodies
por: Rocco, Joseph M., et al.
Publicado: (2021)

Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role
por: Liu, Wenbin, et al.
Publicado: (2019)

Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021)

The Prognostic Value of Anti-PLA2R Antibodies Levels in Primary Membranous Nephropathy
por: Kukuy, Olga Lesya, et al.
Publicado: (2023)

Serum Levels of BAFF and APRIL Predict Clinical Response in Anti-PLA2R-Positive Primary Membranous Nephropathy
por: Netti, Giuseppe Stefano, et al.
Publicado: (2019)

Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach
por: Wang, Song, et al.
Publicado: (2023)

A Case of Severe and Refractory Membranous Nephropathy Associated to Mucous Membrane Pemphigoid
por: Mereniuk, Eric, et al.
Publicado: (2021)

Serum anti-PLA2R antibody and glomerular PLA2R deposition in Chinese patients with membranous nephropathy: A cross-sectional study
por: Pang, Lu, et al.
Publicado: (2017)

Analysis of glomerular PLA2R efficacy in evaluating the prognosis of idiopathic membranous nephropathy in the background of different serum anti-PLA2R levels
por: Sun, Yuemeng, et al.
Publicado: (2022)

The value of PLA2R antigen and IgG subclass staining relative to anti-PLA2R seropositivity in the differential diagnosis of membranous nephropathy
por: Bajcsi, Dóra, et al.
Publicado: (2023)

Successful treatment with bortezomib for refractory fever associated with myelodysplastic syndrome with underlying lymphoplasmacytic lymphoma
por: Motomura, Yotaro, et al.
Publicado: (2022)

Successful Treatment with Bortezomib for Refractory Thrombotic Thrombocytopenic Purpura Associated with Systemic Lupus Erythematosus
por: Yan, Ruyu, et al.
Publicado: (2022)

PLA2R antibody, PLA2R rs4664308 polymorphism and PLA2R mRNA levels in Tunisian patients with primary membranous nephritis
por: Dhaouadi, Tarak, et al.
Publicado: (2020)

Lectin Complement Pathway Activation is Associated with Massive Proteinuria in PLA2R-Positive Membranous Nephropathy: A Retrospective Study
por: Li, Jiayi, et al.
Publicado: (2023)

Temporal Association Between PLA2R Antibodies and Clinical Outcomes in Primary Membranous Nephropathy
por: Ramachandran, R., et al.
Publicado: (2017)

Urine anti-PLA2R antibody is a novel biomarker of idiopathic membranous nephropathy
por: Wang, Yu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_70anottoe2kg3tbd1t6n7j2gq9